NanoEcho’s technology is presented at a surgeon conference
Images generated with NanoEcho’s system were shown for the first time to internationally leading colorectal surgeons at the annual Swedish conference on colorectal surgery.
NanoEcho’s technique – in 60 seconds
Do you want to know more about NanoEcho’s imaging method for rectal cancer diagnosis? Then take a look at the video below, which in 60 seconds explains how the technique, magnetomotive ultrasound, works.
A historic day – for the first time ever, a magnetomotive ultrasound was applied to human tissue
Yesterday was a historic day for NanoEcho. To our knowledge, this is the first time ever that the magnetomotive ultrasound method has been applied to human tissue. This was carried out on operated cancer tissue using NanoEcho’s first generation portable system at Sahlgrenska University Hospital in Gothenburg. Our system is designed to map, with high precision, the spread of cancer to the lymph nodes, an important marker of how far the cancer has progressed, even before surgery. Our clinical study is now underway at Sahlgrenska University Hospital.
Basic patent granted in Japan
The basic patent for NanoEcho’s method has now been granted in Japan. We have also received positive feedback on the same patent in Europe from the European Patent Office, which has announced that it intends to grant the patent. The same patent is also under review in Canada and the US, where the process is also progressing according to plan.
First patient recruited in clinical trial on surgically removed tissue
NanoEcho has been given the go-ahead to begin clinical trials on surgically removed rectal cancer tissue at Sahlgrenska University Hospital in Gothenburg and at Skåne University Hospital in Malmö. The first patient has now been recruited at Sahlgrenska University Hospital. NanoEcho is developing a new medical imaging technique for the diagnosis of rectal cancer. The ambition is to contribute to a more reliable mapping of cancer spread to nearby lymph nodes, which is an important marker of how far along the cancer is.
Ethics application approved for preclinical study at Skåne University Hospital
NanoEcho will conduct a preclinical study led by Henrik Thorlacius, Professor of Surgery at Lund University and Chief Physician at Skåne University Hospital in Malmö, in which NanoEcho’s new instrument for detection of lymph nodes with cancer spread will be evaluated. The study will be carried out at Skåne University Hospital in Malmö and will include about 40 patients that will undergo he usual routine standard surgery. Once the cancer is removed from the patient, the surgical preparate will be examined with NanoEcho’s instrument. The result will then be compared with the pathologist’s final microscopic examination.
NanoEcho publishes investor letter
Read more about CEO Linda Persson and CTO Magnus Santesson as they tell more about their work to establish a strong company culture with a focus on delivery. “It is essential that we ourselves are as driven as our staff, and that we maintain the same commitment that we want to see from them,” says […]